Axon Enterprise — Aug 5, 2026 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001628280-26-053363
Showing in the filing
Future Contracted Bookings expected to be fulfilled over the next 12 months
“between 20% and 25%”
Period
No period stated
Measure
Company-defined measure
Source
Prose
All guidance in this release · 7
Revenue growth for FY2026
“32% to 34%”
Future Contracted Bookings expected to be fu…
“between 20% and 25%”
Five-year normalized bookings growth for FY2026
“greater than 30%”
Adjusted EBITDA margin for FY2026
“25.5%”
Stock-based compensation expense for FY2026
“approximately $590 million to $620 million”
Stock-based compensation expense related to … for FY2026
“approximately $280 million”
CapEx for FY2026
“$160 million to $190 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
T his operational metric tracks total unfulfilled contracted bookings for products and services, including remaining performance obligations as well as contracts with certain ter mination or other clauses that are not otherwise included in remaining performance obligations. We expect to fulfill between 20% and 25% of this balance over the next 12 months and generally expect the remainder to be fulfilled over the following ten years. 2026 Outlook The following forward-looking statements reflect Axon’s expectations as of August 5, 2026 and are subject to risks and uncertainties. Please refer to “ Forward-Looking Statements ” below for additional information. • 2026 Revenue: Axon expects full-year 2026 revenue growth in a range of 32% to 34%, an increase from 30% to 32% previously. Our increased revenue guidance is supported by our continued execution against $15.1 billion in Future Contracted Bookings, and an expanding pipeline that supports our expectation for greater than 30% growth in five-year normalized bookings year over year for 2026. • 2026 Adjusted EBITDA: Axon expects full-year 2026 Adjusted EBITDA margin of 25.5%. ◦ We provide Adjusted EBITDA guidance, rather than net income guidance, due to the inherent difficulty of forecasting certain types of expenses and gains such as income tax expenses and gains or losses on marketable securities and strategic investments, which affect net income but not Adjusted EBITDA. We are unable to reasonably estimate the impact of such expenses, which
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.